This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rosenberg, A. Search for Related Content Social Bookmarking                         What's this?

On the Priority of Intellectual Property Rights, Especially in Biotechnology

Duke University, USA, alexrose{at}duke.edu

This article argues that considerations about the role and predictability of intellectual innovation make the protection of intellectual property morally obligatory even when it greatly reduces short-term welfare. Since the provision of good new ideas is the only productive input not subject to decreasing marginal productivity, welfarist considerations require that no impediment to its maximal provision be erected and the potentially substantial welfare losses imposed by a patent system be mitigated by taxation of other sources of wealth and income.

Key Words: patent system • welfarism • decreasing marginal productivity

Politics, Philosophy & Economics, Vol. 3, No. 1, 77-95 (2004)
DOI: 10.1177/1470594X04039983


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Sonderholm A Reform Proposal in Need of Reform: A Critique of Thomas Pogge's Proposal for How to Incentivize Research and Development of Essential Drugs Public Health Ethics, July 3, 2009; (2009) php017v1. [Abstract] [Full Text] [PDF]

				J Sonderholm Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases J. Med. Ethics, May 1, 2009; 35(5): 315 - 319. [Abstract] [Full Text] [PDF]